SEAMO Clinician Scientist Dr. Neil Renwick Receives Provincial Innovation Fund Award
Project: Optimizing cancer care delivery through maximally informative molecular diagnostics
SEAMO is celebrating a major milestone with the announcement that Dr. Neil Renwick has been selected by the Innovation Fund Provincial Oversight Committee to receive a 2025 Innovation Fund Award in the Cancer category. This marks the first time a SEAMO project has been recognized at the provincial level, and it highlights the depth of impact our clinician scientists bring to patient care and discovery.